Maurizio Pellecchia

Funding Opportunities

Breadcrumb

For information on how to support the center, sponsor research and/or invest in our drug discovery programs, please contact:


2022 Seed Funding Program

UC DDC Request for Proposals, RFA2 2022

Applications are invited for one year of seed-funding support, with funding to start as soon as mid-November.

Applicants will fill out and upload a brief non-confidential Letter of Intent form. The Executive Committee (EC) of UC DDC and UC DDC industrial partner(s)  will review all proposals and invite selected applicants to make an in-person or online presentation at their home campus to the industrial sponsor(s) and EC representatives under a confidentiality obligation of Consortium Member Agreement. Project(s) to be funded will be selected by the Executive Committee in consultation with the industrial partner. Our industrial partner for this request for applications is Astellas Pharma, Inc. 

PIs of funded project must apprise the EC and partner of their progress during the project and must submit a final report after its close. PIs will also be invited to participate in the annual UC-wide drug discovery symposium. 

Researchers considering applying are invited to email a 1-3 sentence, non-confidential statement of their proposed project to their UC DDC Campus Lead for a quick response regarding the partner’s and UC DDC’s level of interest.  The UC DDC Leads are listed here: https://www.ucdrugdiscovery.org/contact.


Four seed grants are anticipated in this cycle.

Budget: You may propose $50,000 up to $100,000 direct costs, which will be accompanied by indirect costs at the campus NIH level.  Final budget will be determined following review and must be commensurate with and clearly tied to the accomplishment of the project. Costs may include salary and benefits, supplies, instrument access, and travel costs.  Given interest from the UC DDC industrial partner, a higher level of funding may be offered to carry out an expanded version of the project, and/or substantial follow-on funding and/or collaboration is possible. 

Deadline for nonconfidential Letters of Intent: Closed


Eligibility: Faculty in all series and ranks at UC Berkeley, UC Davis, UC Irvine, UC Los Angeles, UC Riverside, UC San Diego, UC San Francisco, and UC Santa Cruz are eligible. Postdoctoral scholars, project scientists, and staff researchers are not eligible to serve as principal investigator of a UC DDC seed award unless they have been granted principal investigator status on their campus. Researchers who are UC scientists but not faculty can be listed as co-principal investigators. 

 

For areas of interest, questions, or additional information, please email Center MolMed Director, Maurizio Pellecchia at maurizio.pellecchia@medsch.ucr.edu.